FindTrial
Sign In

Immune Globulin Intravenous (Human)

BIOLOGICAL2 trials

Sponsors

Grifols Therapeutics LLC, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

Antisynthetase SyndromeDermatomyositisImmune-Mediated Necrotizing MyopathyImmunologic Deficiency SyndromeInflammatory Myopathy, IdiopathicMyositisPolymyositis

Phase 2

A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency
CompletedNCT00389324
Grifols Therapeutics LLCImmunologic Deficiency Syndrome
Start: 2006-11-30End: 2008-08-31Updated: 2015-04-20
Add-on Intravenous Immunoglobulins in Early Myositis
Active, not recruitingNCT05832034
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Antisynthetase Syndrome, Dermatomyositis, Immune-Mediated Necrotizing Myopathy +3
Start: 2021-09-13End: 2026-07-01Updated: 2026-02-27